The Nigeria Football Federation (NFF) has revealed that discussions are being held as to how to end the 2019-20 domestic league season due to the covid-19 pandemic. The Nigeria Professional Football League (NPFL), the body responsible for the management of the league, suspended football activities since March due to the coronavirus pandemic.
Boss Mustapha, chairman of the Presidential Task Force on Covid-19 and secretary to the federal government, early this month said the government had no plans to open sporting activities leading the League Management Company (LMC) to propose four options to end the league, including a point-per-game (PPG) method.
Club owners had to vote in favour of the PPG as Plateau United currently lead the NPFL table with 49 points from 25 games while Rivers United are second with 45 points, and both clubs are in the Caf Champions League spots. We will bring you more updates from the NFF as the story develops.
NCDC confirms new cases of coronavirus
452 new cases of #COVID19Nigeria;
533 deaths pic.twitter.com/ZcRAlVR4ro
— NCDC (@NCDCgov) June 23, 2020
UN appoints 2Face as Refugees Ambassador
The United Nations has appointed 2Face has its Refugees Goodwill ambassador. The singer made this know via his Instagram yesterday.
Court restrains Obaseki from participating in PDP primaries
Justice E.A Obile of a Federal High Court sitting in Port Harcourt, has restrained Edo Governor, Godwin Obaseki, from participating in the governorship primaries of the Peoples Democratic Party (PDP) scheduled to hold on Thursday, June 25. Justice Obile gave the order in a suit filed by another PDP governorship aspirant, Omoregie Ogbeide-Ihama, who insisted that Obaseki did not purchase PDP form or undergo screening within the time-table schedule.
South Africa to start Africa’s first coronavirus vaccine trial this week
South Africa, the country with the highest coronavirus cases in Africa, will roll out the first coronavirus vaccine trial in Africa this week.
The vaccine, known as ChAdOx1 nCoV-19, was developed by the Oxford Jenner Institute and it is already being evaluated in Britain, where 4,000 participants have signed up for the trial. South Africa has set out to vaccinate 2,000 people with the vaccine.